Health Atlas
Menu
Evidence-led reference

Products & safety

Menstrual products: absorbent and collecting options, safe use and contaminant evidence

6 sources · Latest source check 2026-10-13 UTC
On this page

Menstrual products manage period fluid by absorbing it or collecting it. Pads and period underwear work outside the vagina; tampons absorb internally; cups collect internally. Placement, material, absorbency, cleaning and replacement instructions differ. Reusable describes a maintenance requirement rather than a guarantee of superior health safety.[1]

Absorption and collection differ

Common product types
CategoryMeaning and limits
Pads and linersAbsorb fluid externally; reusable and disposable versions need different maintenance.[1]
Period underwearExternal absorbent clothing; follow its cleaning instructions.[1]
TamponsInternal absorbent products; FDA-authorized tampons are single use.[2]
CupsInternal collection devices with product-specific insertion, emptying and cleaning instructions.[3]

Timing instructions address a known infection risk

FDA advises changing tampons every four to eight hours, never leaving one longer than eight hours, and choosing the lowest absorbency needed. Wash hands before and after use and follow the package instructions. Toxic shock syndrome is rare but serious; sudden fever, vomiting, diarrhea, faintness or a sunburn-like rash during or soon after a period warrants immediate medical attention. FDA discourages reusable tampons. These cautions concern infection and use, not whether a laboratory detects trace metals.[2]

Evidence & uncertainty

Trace metals in tampon material are a legitimate measurement question. They are not automatically the absorbed dose. FDA’s 2026 laboratory risk assessment was reassuring, while a separate 2026 leaching study called for further absorption research. Those interpretations address different steps between product content and a health outcome.[5]

Selected-source overview · Independent review pending

Published questions

Are pads, tampons and cups doing the same thing?

Selected-source overview · Independent review pending. Read the evidence context.

They manage the same fluid through different placements and mechanisms. Pads and underwear absorb outside the vagina; tampons absorb inside it; cups collect internally. Their use and cleaning instructions differ.[1]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does a very absorbent tampon make prolonged wear safe?

Selected-source overview · Independent review pending. Read the evidence context.

No. FDA advises the lowest absorbency needed, changes every four to eight hours and never more than eight hours of wear. Higher absorbency is not permission to ignore the time limit.[2]

Evidence behind this answer
  • The Facts on Tampons and Tampon Safety

    agency device safety guidance · 2026
    Original current FDA relevant sections inspected · Single-use products; safety tips; toxic-shock symptoms and time limits

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Do menstrual cups always work immediately without practice?

Selected-source overview · Independent review pending. Read the evidence context.

No. The review identified a familiarization phase over several cycles. Leakage comparisons were favorable in limited studies, but fit, learning and product instructions still matter.[3]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does detecting lead in tampon material prove it entered someone’s blood?

Selected-source overview · Independent review pending. Read the evidence context.

No. The 2024 material-content study did not measure release during use or passage into circulation. Content, released quantity and absorbed dose are distinct.[4]

Evidence behind this answer
  • Tampons as a source of exposure to metal(loid)s

    original product lab research · 2024
    Indexed primary abstract excerpts inspected; full text not retrieved · Indexed original abstract: sampling, sixteen metals and unmeasured release/absorption

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

What makes the FDA’s 2026 interpretation reassuring?

Selected-source overview · Independent review pending. Read the evidence context.

It assessed measured release under exaggerated laboratory conditions and calculated toxicological margins of safety. Its negligible-concern conclusion concerns that assessment, not proof of zero exposure or every possible outcome.[5]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does the newer leaching study prove poisoning?

Selected-source overview · Independent review pending. Read the evidence context.

No. It detected metals released into simulated fluids and explicitly distinguished release from vaginal absorption. Further exposure work is needed before assigning a clinical outcome to those amounts.[6]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Cups can be workable, with a learning phase and limitations

The 2019 review included 43 studies with 3,319 participants. Four direct comparisons involving 293 people found leakage similar or lower with cups than with usual pads or tampons. Adoption commonly required several cycles of familiarization. Only a few included studies were moderate-to-high quality. The review identified case reports of pain, urinary problems, toxic shock and intrauterine-device dislodgement. Such reports identify possible complications but do not establish their rate among all cup users or prove that cups have no risk.[3]

The 2024 finding measured material content

A 2024 study measured sixteen metals in thirty tampons from fourteen brands. All sixteen were detected in at least one sampled product. The method measured metal content in material; it did not establish how much escaped during use, crossed vaginal tissue or reached circulation. Organic status did not eliminate every metal. This work supports additional product characterization, while leaving the exposure-to-health-outcome chain unresolved. A concentration found after laboratory digestion is not itself a clinical diagnosis of poisoning.[4]

FDA tested release and modeled toxicological risk

FDA researchers tested eleven legally marketed products. The published 2026 abstract describes exaggerated release conditions: acidified water at 50°C for twenty-four hours. They then used a toxicological assessment based on ISO 10993 and agency guidance; the calculated margins of safety indicated negligible concern from measured metals. This is a laboratory and risk-model conclusion, not a trial measuring long-term disease or a direct human vaginal-absorption study. Its assumptions, tested products and measured release are essential context.[5]

A newer study answers another part of the question

A study published online in August 2026 tested twenty-two products for eight hours at 37°C in simulated vaginal and menstrual fluids. Mean lead release was 40.3 nanograms in vaginal fluid (95% confidence interval 6.94–73.7), versus 15.6 nanograms in menstrual fluid (6.91–24.3). Release varied by conditions and product characteristics. The authors explicitly state that in-vitro release does not equal vaginal absorption or systemic exposure. Detectable release and reassuring modeled risk can coexist; neither alone resolves every cumulative-exposure question.[6]

A draft recommendation is not a finalized standard

FDA’s current overview describes menstrual products as medical devices, with requirements varying by type and some products undergoing premarket review. It still identifies its October 2025 performance-testing and labeling guidance as a draft, intended to supersede older guidance when finalized. Regulatory oversight and product testing are useful safeguards, but do not establish zero adverse events or provide an exhaustive brand-by-brand ranking.[1]

References

  1. Menstrual Product Options, Facts, and Safe Use

    Agency device guidance

    US Food and Drug Administration · Content/publication date: 2026
    Accessed: 2026-10-13 UTC · Original current FDA relevant sections inspected
    Cited sections: Product categories and oversight; October 2025 guidance still described as draft

  2. The Facts on Tampons and Tampon Safety

    Agency device safety guidance

    US Food and Drug Administration · Content/publication date: 2026
    Accessed: 2026-10-13 UTC · Original current FDA relevant sections inspected
    Cited sections: Single-use products; safety tips; toxic-shock symptoms and time limits

  3. Menstrual cup use, leakage, acceptability, safety, and availability

    Original systematic review

    van Eijk et al. · Content/publication date: 2019
    Accessed: 2026-10-13 UTC · Indexed primary abstract excerpts inspected; full text not retrieved
    Cited sections: Indexed original abstract Findings: comparisons, learning phase, quality and reported complications

  4. Tampons as a source of exposure to metal(loid)s

    Original product lab research

    Shearston et al. · Content/publication date: 2024
    Accessed: 2026-10-13 UTC · Indexed primary abstract excerpts inspected; full text not retrieved
    Cited sections: Indexed original abstract: sampling, sixteen metals and unmeasured release/absorption

  5. Do metals in tampons pose a health risk? A toxicological risk assessment study

    Original laboratory risk assessment

    Jin et al. · Content/publication date: 2026
    Accessed: 2026-10-13 UTC · Original abstract inspected; full article not retrieved
    Cited sections: Abstract: eleven products, acidified water at 50°C for 24 hours, risk model and conclusion

  6. In vitro metal leaching from tampons under simulated vaginal and menstrual pH conditions

    Original product lab research

    Kaneshiro et al. · Content/publication date: 2026
    Accessed: 2026-10-13 UTC · Indexed primary abstract excerpts inspected; full text not retrieved
    Cited sections: Indexed original revised abstract: twenty-two products; 37°C, eight hours; lead quantities and limits

Scope & review

Population
General readers; study-specific populations are identified
Exposure or intervention
Menstrual products
Comparison
Source-specific formulation, vehicle, usual care or nonuse; products are not assumed interchangeable
Outcomes
Definitions, practical distinctions, tested outcomes, safety and uncertainty
Timeframe
Selected historical and current evidence checked 2026-10-13
Jurisdiction
US and explicitly identified international sources; local requirements differ

Bounded selected-source educational explanation distinguishing official guidance, study findings and editorial interpretation. No exhaustive search, independent systematic synthesis or qualified clinical review.

Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.

Revision history
  • 2026-10-13 UTC: Added a definition-first explanation with formulation-specific evidence and explicit uncertainty.

What this article still leaves open

  • No individualized device fitting, brand ranking or blood-metal interpretation is supplied.
  • Product-specific absorption, cumulative exposure and long-term outcomes require further investigation.
Suggest a correction

Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.

Explore the topic map

Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.